Table 1 Clinical characteristics of GO patients
From: The critical role of m6A methylation in the pathogenesis of Graves' ophthalmopathy
Patients ID | Gender/age | Months with GO | Months with GD | CAS | Clinical subtype | Smoking status | TRAb (UI/l) | TSH (μUI/ml) | FT4 (ng/dl) | Treatment for GD | Treatment for GO | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Use of ATD (actual) | Cortico-steroids | Cyclos-porine | Surgical | ||||||||||
A | F/69 | 12 | 26 | 5 | II | – | 3.70 | 4.358 | 13.1 | + | + | – | + |
B | F/63 | 20 | 43 | 4 | II | – | 2.73 | 3.137 | 17.93 | – | + | – | + |
C | F/40 | 6 | 10 | 5 | II | + | 1.38 | 1.689 | 16.36 | + | + | – | + |
D | F/52 | 9 | 9 | 6 | II | – | 7.34 | 0.079 | 17.33 | + | + | + | + |
E | M/57 | 6 | 20 | 3 | II | + | 8.58 | 2.258 | 18.03 | + | + | – | + |
F | M/35 | 7 | 30 | 3 | II | – | 5.33 | 2.512 | 14.23 | + | + | – | + |
G | F/36 | 11 | 13 | 2 | II | – | 2.46 | 0.055 | 13.38 | + | + | – | + |